The FDA Issued a Recall on Bladder Medication Nationwide
Synmosa must recall 87,360 tablets after a dissolution test found the blood pressure medicine may not work as intended, the TFDA said.
8 Articles
8 Articles
Recall ordered for batch of hypertension drugs
The Food and Drug Administration (FDA) yesterday ordered a recall of a batch of hypertension drug, consisting of 87,360 tablets.The FDA said it received notification of a defective drug product — Beniel F.C. Tablets 8mg, batch code 2KA31 — manufactured by Synmosa Biopharma Corp. The batch was regist
Common Blood Pressure Drug Recalled Nationwide, FDA Says
Novartis Pharmaceuticals Corporation recalled some heart failure and high blood pressure medication due to potency issues, according to the Food and Drug Administration’s website. The recall affects one lot of Diovan, Novartis’ valsartan brand, according to a report issued last week. The lot includes 160-milligram tablets in 90-count bottles, with the lot number AV5913C, and an expiration date of June 2027. The drug is prescription-only and manu…
TFDA orders recall of over 87,000 antihypertensive tablets
Taipei, Aug. 12 (CNA) The Taiwan Food and Drug Administration (TFDA) has ordered the recall of 87,360 tablets of the antihypertensive drug Beniel F.C. Tablets 8 mg manufactured by Synmosa Biopharma Corp. over concerns that the medication may not work as intended, the agency said Wednesday.
The Food and Drug Administration (FDA) recently issued a drug recall notice. The hypertension medication "Pantir Film-Coated Tablets 8 mg" was found to have a dissolution test result lower than the specification during the stability test, which may affect the quality and efficacy stability of the drug. A recall operation has been initiated for one batch, involving 87,360 tablets, and is expected to be completed by August 24.
Coverage Details
Bias Distribution
- 57% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium






